Journal article

Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity

Frontiers in pharmacology, 2017. Djillani A, Pietri M, Moreno S and 3 others.

Study type

Journal article

Subjects

Not classified in PubMed MeSH

Journal

Frontiers in pharmacology

Published

2017

PubMed

PMID 28955242 ↗

DOI

10.3389/fphar.2017.00643 ↗

Full text

Free on PubMed Central (PMC5601071) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

PE-22-28 →

Other papers on PE-22-28

Review · 2019

Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin

Journal article · 2021

Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice

Journal article · 2018

The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page